227 related articles for article (PubMed ID: 21061431)
1. Myeloid-derived suppressor cells in parasitic infections.
Van Ginderachter JA; Beschin A; De Baetselier P; Raes G
Eur J Immunol; 2010 Nov; 40(11):2976-85. PubMed ID: 21061431
[TBL] [Abstract][Full Text] [Related]
2. Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells.
Michel A; Schüler A; Friedrich P; Döner F; Bopp T; Radsak M; Hoffmann M; Relle M; Distler U; Kuharev J; Tenzer S; Feyerabend TB; Rodewald HR; Schild H; Schmitt E; Becker M; Stassen M
J Immunol; 2013 Jun; 190(11):5534-44. PubMed ID: 23636054
[TBL] [Abstract][Full Text] [Related]
3. Polyparasitism and its impact on the immune system.
Supali T; Verweij JJ; Wiria AE; Djuardi Y; Hamid F; Kaisar MM; Wammes LJ; van Lieshout L; Luty AJ; Sartono E; Yazdanbakhsh M
Int J Parasitol; 2010 Aug; 40(10):1171-6. PubMed ID: 20580905
[TBL] [Abstract][Full Text] [Related]
4. Sex steroids, immune system, and parasitic infections: facts and hypotheses.
Nava-Castro K; Hernández-Bello R; Muñiz-Hernández S; Camacho-Arroyo I; Morales-Montor J
Ann N Y Acad Sci; 2012 Jul; 1262():16-26. PubMed ID: 22823431
[TBL] [Abstract][Full Text] [Related]
5. [Apoptosis, a protective mechanism for pathogens and their hosts].
Donskow-Schmelter K; Doligalska M
Wiad Parazytol; 2005; 51(4):271-80. PubMed ID: 16913499
[TBL] [Abstract][Full Text] [Related]
6. Myeloid cell population dynamics in healthy and tumor-bearing mice.
Ueha S; Shand FH; Matsushima K
Int Immunopharmacol; 2011 Jul; 11(7):783-8. PubMed ID: 21406269
[TBL] [Abstract][Full Text] [Related]
7. The other side of the coin: the protective role of the TH2 cytokines.
Finkelman FD; Urban JF
J Allergy Clin Immunol; 2001 May; 107(5):772-80. PubMed ID: 11344341
[TBL] [Abstract][Full Text] [Related]
8. microRNAs as potential regulators of myeloid-derived suppressor cell expansion.
El Gazzar M
Innate Immun; 2014 Apr; 20(3):227-38. PubMed ID: 23757323
[TBL] [Abstract][Full Text] [Related]
9. On the origin of myeloid-derived suppressor cells.
Millrud CR; Bergenfelz C; Leandersson K
Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299
[TBL] [Abstract][Full Text] [Related]
10. Immunoendocrine host-parasite interactions during helminth infections: from the basic knowledge to its possible therapeutic applications.
Hernández-Bello R; Escobedo G; Guzmán C; Ibarra-Coronado EG; López-Griego L; Morales-Montor J
Parasite Immunol; 2010; 32(9-10):633-43. PubMed ID: 20691015
[TBL] [Abstract][Full Text] [Related]
11. Protection and pathology during parasite infection: IL-10 strikes the balance.
Redpath SA; Fonseca NM; Perona-Wright G
Parasite Immunol; 2014 Jun; 36(6):233-52. PubMed ID: 24666543
[TBL] [Abstract][Full Text] [Related]
12. Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis.
Wu C; Ning H; Liu M; Lin J; Luo S; Zhu W; Xu J; Wu WC; Liang J; Shao CK; Ren J; Wei B; Cui J; Chen MS; Zheng L
J Clin Invest; 2018 Aug; 128(8):3425-3438. PubMed ID: 29771686
[TBL] [Abstract][Full Text] [Related]
13. The beneficial helminth parasite?
McKay DM
Parasitology; 2006 Jan; 132(Pt 1):1-12. PubMed ID: 16393348
[TBL] [Abstract][Full Text] [Related]
14. Immune regulation by helminth parasites: cellular and molecular mechanisms.
Maizels RM; Yazdanbakhsh M
Nat Rev Immunol; 2003 Sep; 3(9):733-44. PubMed ID: 12949497
[TBL] [Abstract][Full Text] [Related]
15. Protozoan parasites: programmed cell death as a mechanism of parasitism.
Bruchhaus I; Roeder T; Rennenberg A; Heussler VT
Trends Parasitol; 2007 Aug; 23(8):376-83. PubMed ID: 17588817
[TBL] [Abstract][Full Text] [Related]
16. [Immunoprophylaxis and pathology of parasitic infection].
Seinen W
Tijdschr Diergeneeskd; 1983 Jan; 108(1):27-33. PubMed ID: 6868050
[TBL] [Abstract][Full Text] [Related]
17. Granulocytes: effector cells or immunomodulators in the immune response to helminth infection?
Cadman ET; Lawrence RA
Parasite Immunol; 2010 Jan; 32(1):1-19. PubMed ID: 20042003
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
19. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy.
Talmadge JE
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5243-8. PubMed ID: 17875751
[TBL] [Abstract][Full Text] [Related]
20. [Current changes in human parasitic infections in Japan].
Osaki H
Rinsho Byori; 1984 Jan; 32(1):59-65. PubMed ID: 6737723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
